Weekly Risperidone Win; Meta Hides Harmful Teen Content; Breathing to Altered State?

(MedPage Today) -- A once-weekly version of oral risperidone (LYN-005) was comparable to daily dosing with immediate-release risperidone (Risperdal) for schizophrenia and schizoaffective disorder in the phase III STARLYNG-1 trial, said developer...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news